What are the prevalence, timing, and potential baseline clinical risk factors associated with patients with medically refractory chronic rhinosinusitis (CRS) electing to change from continued medical therapy (CMT) (with or without surgery) to endoscopic sinus surgery (ESS)?
Bottom Line: Baseline total SNOT-22 and endoscopy scores are associated with treatment crossover, but reported sleep dysfunction is the only significant independent predictor of treatment crossover.
Explore this issue:April 2018
Background: At some point, patients with CRS who do not experience adequate symptom control will decide whether to continue with appropriate medical therapies or to elect ESS followed by CMT. An improved understanding of both the prevalence and incidence of escalation of care toward ESS would help patients and otolaryngologists to more efficiently navigate the choices and expectations between treatments.
Study design: Retrospective analysis of a prospective, multi-center cohort of 179 adult patients with CRS enrolled between March 2011 and June 2015.| | | Next → | Single Page